Rouses Point Pharm

Rouses Point Pharmaceuticals was a specialty pharmaceutical company and manufacturing entity located in Rouses Point, New York. Formed as an affiliate of Akrimax Pharmaceuticals, the company acquired a significant manufacturing plant from Wyeth (now Pfizer) to produce and market legacy branded and generic medications. Its portfolio notably included cardiovascular treatments such as Inderal (propranolol) and Isordil (isosorbide dinitrate). The company operated as a Contract Manufacturing Organization (CMO) and a generic drug labeler, leveraging the extensive infrastructure of the former Wyeth site. Following its peak operations, the facility underwent several ownership transitions, including a sale to EPharma, before eventually facing bankruptcy and closure.